Introduction {#S1}
============

Prolonged exposure to microgravity is associated with multi-system deconditioning including the cardiovascular ([@B25]) and musculoskeletal systems ([@B46]). For instance, spaceflight-induced decrements in bone mineral density ([@B63]) and skeletal muscle mass ([@B13]) are common, particularly in lower-limb muscles ([@B38]). Despite the considerable subject variability in the extent of muscle atrophy and functional loss, one of the most affected muscles seems to be the triceps surae, for which muscle fiber atrophy of 20% has been observed after 6 months of spaceflight ([@B12]; [@B13]). Long-term spaceflight is also known to impair functionality ([@B45]), neuromuscular control ([@B5]) and skeletal muscle strength ([@B58]; [@B53]), with the strength decline primarily reflecting the loss of muscle mass ([@B13]). Since the Skylab missions, it has been known that spaceflight induces more weakness in thigh than arm muscles, particularly the knee extensors, for which ∼20% of strength loss was reported after 1- and 2-month missions ([@B12]). Recent studies suggest that in some individuals there are persistent neuromuscular control issues - compounded by and/or related to neurovestibular dysfunction (e.g., [@B61]) - resulting in extended periods of physical rehabilitation upon return to Earth ([@B37]; [@B48]).

Besides muscle atrophy, spaceflight-related muscle weakness appears also to reflect a number of neuromuscular alterations, including a selective transformation of slow muscle fibers (type I) to faster phenotypes (type II) ([@B59]). In fact, there is evidence that slow muscle fibers are predominantly affected by spaceflight ([@B12]; [@B70]; [@B52]; [@B68]). Recent pilot data from the SARCOLAB study also suggest that reduced plantar flexor muscle volume may be associated with altered muscle architecture, contractile protein composition, and impaired muscle fiber contractility ([@B51]).

Exercise Training as a Countermeasure {#S1.SS1}
-------------------------------------

In order to address microgravity-induced deconditioning, exercise countermeasure training is performed daily on the International Space Station (ISS) ([@B24]). Despite the medical standard agreements between the ISS international partners, each partner utilizes different training regimes that are to some extent individually tailored for each crewmember. For example, exercise countermeasures in the United States operating segment (NASA, ESA, JAXA, and CSA) consist of an integrated resistance and aerobic training schedule employing the advanced resistive exercise device (ARED), the second generation treadmill (T2), and a cycle ergometer with vibration isolation and stabilization (CEVIS) ([@B47]). In contrast, the Russian operating segment employs the ![](fphys-10-01031-i001.jpg) treadmill, the ![](fphys-10-01031-i002.jpg) cycle ergometer, and the force loader (HC)-1 installed on the ![](fphys-10-01031-i002.jpg) ergometer ([@B71]). These tools are complemented by a set of resistance bands, compression thigh cuffs, lower body negative pressure trousers, suits for lower body compression and postural (axial) loading and also an electrical stimulator.

Despite the significant investment in both resources and crew time, astronauts typically require a period of rehabilitation upon return to Earth ([@B37]; [@B48]), indicative that deconditioning is not entirely prevented ([@B10]; [@B54]). In fact, there appears to be significant variability in the relative effectiveness of ISS countermeasures across various physiological systems ([@B69]), but also between individuals ([@B51]). The current countermeasure regimes appear unable to fully counteract muscle atrophy and weakness during long-duration ISS missions. For example, even high-volume aerobic training (∼500 km of running) complemented with high-intensity resistance training (∼5000 high-intensity heel raises) were insufficient to prevent plantar flexor weakness and atrophy during a 6-month ISS mission ([@B51]). Furthermore, the current countermeasures require significant time and effort (both for exercise itself and for setup/stowage) in addition to potentially interfering with other crewmember tasks, including experimentation. This explains the increasing attention devoted to consider low-volume, simple and complementary exercise modalities, for use throughout, or potentially for only a short period prior to re-exposure to a gravitational vector, be it Earth, or the hypogravity of the Moon. One of those easily applicable and potentially powerful countermeasures -- neuromuscular electrical stimulation (NMES) -- is the focus of this article.

Rationale for NMES {#S1.SS2}
------------------

Neuromuscular electrical stimulation involves delivering pre-programmed trains of stimuli to superficial muscles via self-adhesive skin electrodes connected to small portable current generators. Such electrical stimuli can be used to evoke relatively strong (albeit sub-maximal) muscle contractions, whose activation pattern is substantially different from that of voluntary contractions. NMES recruits motor units in a non-selective, spatially fixed, and temporally synchronous pattern ([@B23]), with the advantage of activating fast muscle fibers at relatively low force levels, but produces greater muscle fatigue when compared with voluntary actions. If provided repeatedly, NMES improves muscle strength, power and endurance in healthy individuals ([@B20]; [@B62]), even though these effects are not superior to those induced by voluntary training ([@B2]). More importantly, NMES has been shown to preserve/restore muscle mass and aspects of neuromuscular function during/following a period of reduced activity due to illness, injury or surgery ([@B8]; [@B26]; [@B56]; [@B42]), with greater effectiveness compared to other rehabilitation modalities ([@B2]). As such, NMES is widely used as a rehabilitation strategy for patients with a range of diseases ([@B26]; [@B56]), both during and following prolonged physical inactivity. NMES also provides beneficial effects in healthy subjects undergoing short periods of ground-based models of microgravity-induced deconditioning, e.g., bed rest or limb immobilization ([@B8]). The majority of terrestrial NMES research has involved stimulation of knee extensor and/or plantar flexor muscles, whose atrophy and weakness can significantly impair locomotion. Although traditional countermeasures have the potential to partially attenuate spaceflight-induced muscle alterations ([@B13]), no direct comparison of the effectiveness of these countermeasures versus NMES currently exists.

As such, this mini-review is focused on the use of NMES as a potentially-complementary countermeasure against skeletal muscle atrophy and weakness induced by human spaceflight. We provide an overview of the rationale and evidence for NMES-based terrestrial state-of-the-art knowledge, compare this to that employed in orbit and in ground-based analogs, and provide practical recommendations for possible NMES implementation in future space (or analog) missions.

NMES in Orbit: Sub-Optimal Use and Evidence {#S2}
===========================================

Roscosmos have employed different NMES devices (see top of [Table 1](#T1){ref-type="table"}) in orbit and in ground-based analogs ([@B33]). The Tonus-3 unit ([@B71]) possesses four programs designed to stimulate: calf and quadriceps; calf and hamstring; calf, abdominal and back muscles; and shoulder muscles. Pulses have a duration of 1 ms and maximum current amplitude is ∼300 mA. Stimulation frequency is 10 kHz modulated at 60 Hz. Stimulation (ON) time is 0.5/1.5 s with a non-stimulation (OFF) period of 1.5 s, or alternatively an ON time of 10 ± 1 s with an OFF time of 50 ± 5 s. Another Russian stimulator, the Stimul-01 HF Set, generates high-frequency alternating sinusoidal electrical stimuli at 2.5 kHz with rectangular pulses modulated at 50 Hz. This device is intended for 40-min stimulation periods of lower limb, back, neck, shoulder and arm muscles, although few details have been published ([@B35]). The Stimul-01 LF Set, a wearable NMES system, was uploaded to the ISS in 2006 ([@B71]) based on data suggesting that low-frequency stimulation is an effective countermeasure against the effects of ground-based (dry immersion) gravitational unloading ([@B35]). The Stimul-01 LF Set provides NMES for 1 s followed by 2 s intervals. The symmetrical bipolar rectangular pulses have a duration of 1 ms and are delivered at 25 Hz, a stimulation pattern considered compatible with work-day activities without being unduly uncomfortable.

###### 

In orbit and ground-based analog NMES devices/studies and recommendations for NMES use in spaceflight.

  **\[Device\]/(Study)**   **Disuse model**                       **Duration (days)**   **NMES Muscle**           **NMES Duration**       **NMES freq (Hz)**   **NMES on:off (s)**                                                                        **NMES Intensity**                  ***Positive effect on muscle mass?***   ***Positive effect on muscle strength?***
  ------------------------ -------------------------------------- --------------------- ------------------------- ----------------------- -------------------- ------------------------------------------------------------------------------------------ ----------------------------------- --------------------------------------- -------------------------------------------
  \[Tonus-3\]              Russian Space Station                                        Multiple muscles                                  10,000(60)           1.5:1.5 10:50                                                                                                                                                          
  \[Stimul-01 HF Set\]     Russian Space Station                                        Multiple muscles                                  2,500(50)                                                                                                                                                                                   
  \[Stimul-01 LF Set\]     Russian Space Station                                        Multiple muscles                                  25                   1:2                                                                                                                                                                    
  [@B43]                   Space Station (proposal)               /                     Lower limbs               6 h/day                 25--50               1:2                                                                                        20--30% max tetanic force           /                                       /
  [@B53]                   ISS (*n* = 1; ? years)                 30 (188-d stay)       Upper arm                 47 min/week (3×/week)   ?                    2:2                                                                                        80% max comfortable intensity       YES                                     NO
  [@B21]                   Long-leg cast (*n* = 10; 20 years)     14                    Lower limbs               16 h/day                37                   5:150                                                                                      Tolerance                           YES                                     ∼
  [@B16]                   Long-leg cast (*n* = 7; 26 years)      40                    Quad                      60 min/day              30                   2:9                                                                                        Visible contraction (5% MVC)        YES                                     /
  [@B9]                    Bed rest (*n* = 3; 36 years)           30                    Lower limbs               40 min/day (2×/day)     60                   4:16                                                                                       Tolerance (torque recording)        YES                                     YES
  [@B8]                    Full-leg cast (*n* = 12; 23 yrs)       5                     Quad                      80 min/day (2×/day)     100                  5:10                                                                                       Visible palpable full contraction   YES                                     NO
  [@B50]                   Bed rest (*n* = 10; 70 years)          5 (with proteins)     Quad                      120 min/day (3×/day)    75                   4:10                                                                                       Max tolerated intensity             YES                                     NO
  [@B72]                   Unloading device (*n* = 7; 26 years)   60 (with proteins)    Calf                      40 min/day (2×/day)     30                   5:5                                                                                        Max tolerated intensity             YES                                     ∼
  **Recommendations**                                             **Quad Calf**         **60 min/day (2x/day)**   **30**                  **5:10**             **5 min to reach max tolerated intensity, then increased whenever possible to ≥20% MVC**                                                                               

In gray, in orbit devices/studies (the others are analogs). In bold, recommendations for future implementation of NMES in space. ISS, International Space Station; MVC, maximal voluntary contraction. ∼ = Inconsistent; ? = Unknown.

[@B43] described an EMG-NMES system (MYOSTIM-FES) embedded into a fabric garment for delivering NMES to the main lower-limb muscle groups ([Table 1](#T1){ref-type="table"}). The astronaut using this system was reported to be "in a much better condition during flight and after landing" ([@B14]), although no supporting data were published. In another ISS study, NMES was delivered in the final 30 days of a 188-day mission. A 12% increase in triceps brachii muscle volume within a single astronaut was demonstrated, while muscle volume of the non-stimulated triceps was essentially unchanged ([@B53]). Whilst limited, these data suggest that NMES application during spaceflight is feasible and potentially able to (at least partially) prevent muscle atrophy. However, currently there is a paucity of data on both NMES effectiveness in orbit, and an evidence-based rationale for its optimal use.

NMES in Ground-Based Analogs {#S3}
============================

The major underlying cause of muscle atrophy in microgravity is a net negative muscle protein balance ([@B49]; [@B67]). Given the challenge of experimentation and countermeasures testing in space, ground-based models of microgravity such as tilted head-down bed rest, lower-limb immobilization or axial unloading are generally used. Such models have demonstrated a substantial decrease in postabsorptive and postprandial muscle protein synthesis ([@B15]; [@B11]; [@B3]; [@B17]; [@B66]; [@B64]), which is suggested to be accompanied by an increase in muscle protein breakdown in the early phase of disuse ([@B60]; [@B1]; [@B64]). Even if the impact of spaceflight on muscle protein turnover has yet to be investigated, a similar decrease in whole-body protein synthesis was observed following long-term (\>3 months) spaceflight ([@B57]). Although it remains to be established whether the same holds true for muscle (rather than whole-body) protein turnover, countermeasures which stimulate muscle protein synthesis, while simultaneously suppressing muscle protein breakdown, are likely to be effective in partially preventing muscle atrophy during prolonged spaceflight.

Long-duration bed rest induces significant muscle weakness and atrophy ([@B45]). Dry immersion has been shown to elicit rapid and profound losses of lower limb-muscle contractile properties e.g., triceps surae ([@B34]; [@B28], [@B29]), similar to those observed in-flight ([@B32]), with signs of muscle denervation appearing after only 3 days ([@B6]). The effects of daily low- and high-frequency NMES upon lower-limb muscles were evaluated during 7 days of dry immersion and 105 days of isolation ([@B31]; [@B33]; [@B30]). Low-frequency stimulation was effective in counteracting triceps surae force-velocity property decrements, particularly with high stimulation intensities.

Various NMES protocols have been employed in a range of ground-based analog studies in an attempt to attenuate muscle atrophy and weakness in healthy subjects ([Table 1](#T1){ref-type="table"}). Despite the diversity in NMES parameters and protocols between studies (ranges for duration: 40 min to 16 h per day; frequency: 30 to 100 Hz; intensity: visible contraction to maximum tolerated current), a common finding is that daily NMES is an effective countermeasure to prevent the loss of lower-limb muscle mass associated to short-term disuse (from 5 to 60 days) as a result of casting ([@B21]; [@B16]; [@B8]), bed rest ([@B9]; [@B50]) and axial unloading ([@B72]). Mechanistically, this is probably due to an increase/maintenance of muscle protein synthesis ([@B16]; [@B65]), but may also be accompanied by a suppression of muscle protein breakdown ([@B8]). NMES might also affect other intramuscular processes including (but not limited to) emission of reactive oxygen species, insulin signaling and substrate utilization, but this is outside the scope of this mini-review ([@B44]; [@B73]). Whilst NMES preserved muscle strength in one of the analog studies ([@B9]), the effects have been inconsistent ([Table 1](#T1){ref-type="table"}). As such, despite the clear potential of NMES to maintain muscle mass during unloading \[particularly when complemented with protein supplementation ([@B7])\], careful definition of NMES implementation is vital to ensure optimal muscle functional outcomes.

State-of-Knowledge on Terrestrial NMES {#S4}
======================================

Much work has been conducted to identify the optimal evidence-based NMES parameters/protocols for neuromuscular training/rehabilitation ([@B41]; [@B42]). One of the main conclusions is that the externally-controllable parameters (e.g., current and electrode characteristics) have a minor impact on NMES effectiveness ([@B39]). In fact, NMES utilization has varied substantially between in orbit, ground-based analog and terrestrial studies (see [Table 1](#T1){ref-type="table"}), despite calls for standardization as long as 30 years ago ([@B55]).

There is, however, increasing evidence that NMES effectiveness is proportional to the amount of evoked force/tension ([@B19]). This is generally expressed as a percentage of the maximal voluntary strength, and is referred to as "NMES training intensity." For example, in [@B36] two groups of healthy volunteers had their quadriceps stimulated for 3 weeks at low vs. high NMES training intensities. NMES effectiveness, defined as an improvement in maximal strength mediated by NMES, was linearly related to NMES training intensity (+24 and +48% in respective groups). Therefore, NMES training intensity, not current intensity/subjective current level or any other stimulation parameter, should be (1) considered as the main determinant of NMES effectiveness, (2) quantified whenever possible on an individual basis, and (3) maximized whenever possible by means of multiple subterfuges (see e.g., [@B41]). Methodologically, at least four simple strategies are able to amplify the muscle response to NMES while minimizing the current-induced discomfort (i.e., the main limitation of NMES): (1) localizing the muscle motor point (i.e., the skin area above the stimulated muscle where the motor threshold is the lowest for a given electrical pulse) ([@B18]); (2) implementing a familiarization period of a few days; (3) providing control of the stimulation unit directly to the participant; (4) allowing the participant to contract the stimulated muscle voluntarily to divert attention from pain/discomfort induced by NMES ([@B41]).

Future NMES Recommendations for Spaceflight {#S5}
===========================================

Based on terrestrial best practice we recommend the following approach for possible NMES utilization in future space missions, including long-term exploration (see also bottom of [Table 1](#T1){ref-type="table"}). NMES should be seen as a complement to, rather than a substitute for pre-existing exercise countermeasures. This implies careful planning of daily exercise training by considering that NMES is performed in static conditions -- so that other non-physical tasks can be executed concomitantly -- and separately from the other exercise modalities (i.e., NMES is not superimposed to running, cycling or rowing).

General Settings {#S5.SS1}
----------------

Simultaneous bilateral stimulation of quadriceps femoris and triceps surae muscles should be performed using two large rectangular/elliptical electrodes per muscle (one distal and one proximal) using a space-compatible portable 4-channel stimulator. Astronauts should be in a seated position, with knee and ankle joints restrained at 90°. This knee angle is known to reduce the involvement of the biarticular gastrocnemii, which are less susceptible to muscle atrophy than the soleus ([@B13]). In this static position, reasonable levels of muscle tension can be generated even in the absence of gravity (tension will be much lower if limb movement is permitted), which is an important prerequisite for maintaining/increasing the force generating capacity of a muscle ([@B40]).

Current-Related Settings {#S5.SS2}
------------------------

Biphasic sinusoidal/rectangular pulses with a duration of at least 400--600 μs should be used, with an OFF time at least twice the ON time (e.g., 5 s ON:10 s OFF). Stimulation frequency should be close to 30 Hz to ensure full tetanic contractions while minimizing fatigability ([@B56]).

Before Spaceflight {#S5.SS3}
------------------

Prior to flight, muscle motor points should be localized and marked on the skin according to the methodology proposed by Gobbo and co-workers ([@B18]). A familiarization period of ∼1 week (3--5 short sessions) should be performed to improve tolerance and thus adherence, whilst also minimizing any risk of muscle damage. Critically, the individual current intensity-evoked force relationship should be determined for each stimulated muscle group of each crewmember, which would require the use of a dynamometer (such as the MARES).

During Spaceflight {#S5.SS4}
------------------

Neuromuscular electrical stimulation should ideally be performed twice daily, with stimulation periods of ∼30 min. Current intensity should be progressively increased to the maximally tolerated level during the first 5 min of each session, to ensure strong muscle contractions. Current intensity should thereafter be increased throughout the entire session, ideally whenever possible. At the end of each session, average current intensity (per channel/muscle), discomfort (0--10 scale) and maximal evoked force (if available) should be recorded. NMES should preferably be combined with protein ingestion to augment its effect on muscle mass ([@B7]).

Remaining NMES Space Challenges {#S6}
===============================

Whilst NMES-based resistance training has potential as an inflight countermeasure, it has some limitations such as the inability to activate the entire muscle ([@B41]), issues with dose and tolerance (discomfort) but no long-term safety concerns ([@B42]), and unclear effects upon other physiological systems known to decondition in space (e.g., skeletal or cardiovascular systems). Nevertheless, knowledge of the methodological and physiological specificities of NMES would allow end-users to optimally apply NMES as a complement to other countermeasures for preserving lower-limb functionality ([@B41]).

This mini-review has focused upon muscles acting around the knee and ankle joints. Nevertheless, other muscle groups such as back extensors ([@B4]) have been shown to decondition in space, leading to functional and operational consequences ([@B22]). Whilst NMES has recently been used upon other muscle groups and multiple body segments simultaneously ([@B27]), as well as with agonist-antagonist co-contraction ([@B53]), these modalities appear unsuitable at this stage because of practical considerations and lack of convincing evidence.

Conclusion {#S7}
==========

Due to the significant discrepancies between the terrestrial (clinical and experimental) NMES state-of-the-art, and that currently performed in orbit and in analog studies, it is crucial to use optimal NMES knowledge on Earth to revisit and further develop NMES as a feasible strategy for human spaceflight exploration.
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